Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clinuvel Pharmaceuticals Ltd (OTC Pink - Current Information:CLVLY)

1.92
Delayed Data
As of Aug 27
 0.00 / 0.00%
Today’s Change
1.83
Today|||52-Week Range
5.00
-43.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$81.5M

Company Description

Clinuvel Pharmaceuticals Ltd. operates as a global biopharmaceutical company, which is focused on the development of SCENESSE, its proprietary photoprotective drug. It also focuses on developing drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

Contact Information

Clinuvel Pharmaceuticals Ltd.
190 Queen Street
Melbourne Victoria (vic) 3000
P:(139) 660-4900
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Philippe J. WolgenChief Executive Officer, Director & MD
Darren M. KeamyChief Financial Officer & Secretary
Dennis J. WrightChief Scientific Officer
Lachlan HayMedia Relations